Decoding Cancer.
Empowering Life.
Uniting clinical insights and molecular precision through AI. We empower partners with advanced solutions and support patients with compassionate, full-cycle care.
Treating the individual,
not just the disease.
At OrigiMed, we believe that every cancer patient deserves a treatment plan as unique as their DNA. By combining high-throughput genomic sequencing with advanced AI analytics, we unlock the secrets hidden within the tumor genome to guide precise, effective therapeutic strategies.
Accelerating Discovery with Precision Data
We partner with leading biopharma companies to transform drug development. Our comprehensive genomic database and AI capabilities provide the insights needed to bring life-saving therapies to market faster.
Companion Diagnostics
Co-development of biomarkers to identify the right patients for the right drugs.
R&D Acceleration
AI-driven target discovery to speed up the drug development pipeline.
Real-World Data
Secure, compliant integration of clinical and genomic data to support regulatory approval and market access.
Based on your latest genomic report, we've identified a potential match for a new targeted therapy trial. Would you like to review the eligibility criteria?
Yes, please show me the details.
Your Personal AI Health Guardian
Navigating cancer treatment is complex. Our AI-powered platform stays with you every step of the way, providing real-time analysis of your health data, treatment monitoring, and personalized care recommendations.